BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 36795405)

  • 1. Association of Social Determinants and Tumor Biology With Racial Disparity in Survival From Early-Stage, Hormone-Dependent Breast Cancer.
    Hoskins KF; Calip GS; Huang HC; Ibraheem A; Danciu OC; Rauscher GH
    JAMA Oncol; 2023 Apr; 9(4):536-545. PubMed ID: 36795405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Within-stage racial differences in tumor size and number of positive lymph nodes in women with breast cancer.
    McBride R; Hershman D; Tsai WY; Jacobson JS; Grann V; Neugut AI
    Cancer; 2007 Sep; 110(6):1201-8. PubMed ID: 17701948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States.
    Iqbal J; Ginsburg O; Rochon PA; Sun P; Narod SA
    JAMA; 2015 Jan; 313(2):165-73. PubMed ID: 25585328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial disparities in adoption of axillary sentinel lymph node biopsy and lymphedema risk in women with breast cancer.
    Black DM; Jiang J; Kuerer HM; Buchholz TA; Smith BD
    JAMA Surg; 2014 Aug; 149(8):788-96. PubMed ID: 25073831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
    Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
    JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Social Determinants of Racial Disparities in Breast Cancer Mortality Among Black and White Women.
    Babatunde OA; Eberth JM; Felder T; Moran R; Truman S; Hebert JR; Zhang J; Adams SA
    J Racial Ethn Health Disparities; 2021 Feb; 8(1):147-156. PubMed ID: 32385849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis.
    Menashe I; Anderson WF; Jatoi I; Rosenberg PS
    J Natl Cancer Inst; 2009 Jul; 101(14):993-1000. PubMed ID: 19584327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the Surveillance, Epidemiology, and End Results data.
    Schinkel JK; Zahm SH; Jatoi I; McGlynn KA; Gallagher C; Schairer C; Shriver CD; Zhu K
    Cancer Causes Control; 2014 Aug; 25(8):959-68. PubMed ID: 24839049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Racial Disparity in Survival Outcomes for Early Hormone Receptor-Positive Breast Cancer After Adjusting for Insurance Status and Neighborhood Deprivation: A Post Hoc Analysis of a Randomized Clinical Trial.
    Sadigh G; Gray RJ; Sparano JA; Yanez B; Garcia SF; Timsina LR; Obeng-Gyasi S; Gareen I; Sledge GW; Whelan TJ; Cella D; Wagner LI; Carlos RC
    JAMA Oncol; 2022 Apr; 8(4):579-586. PubMed ID: 35175284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Race and risk of subsequent aggressive breast cancer following ductal carcinoma in situ.
    Liu Y; West R; Weber JD; Colditz GA
    Cancer; 2019 Sep; 125(18):3225-3233. PubMed ID: 31120565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Race/Ethnicity and the 21-Gene Recurrence Score With Breast Cancer-Specific Mortality Among US Women.
    Hoskins KF; Danciu OC; Ko NY; Calip GS
    JAMA Oncol; 2021 Mar; 7(3):370-378. PubMed ID: 33475714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.
    Warner ET; Tamimi RM; Hughes ME; Ottesen RA; Wong YN; Edge SB; Theriault RL; Blayney DW; Niland JC; Winer EP; Weeks JC; Partridge AH
    J Clin Oncol; 2015 Jul; 33(20):2254-61. PubMed ID: 25964252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neighborhood disadvantage and individual-level life stressors in relation to breast cancer incidence in US Black women.
    Barber LE; Zirpoli GR; Cozier YC; Rosenberg L; Petrick JL; Bertrand KA; Palmer JR
    Breast Cancer Res; 2021 Nov; 23(1):108. PubMed ID: 34809694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.
    Ma H; Lu Y; Malone KE; Marchbanks PA; Deapen DM; Spirtas R; Burkman RT; Strom BL; McDonald JA; Folger SG; Simon MS; Sullivan-Halley J; Press MF; Bernstein L
    BMC Cancer; 2013 May; 13():225. PubMed ID: 23642215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neighborhood Deprivation and Breast Cancer Mortality Among Black and White Women.
    Barber LE; Maliniak ML; Moubadder L; Johnson DA; Miller-Kleinhenz JM; Switchenko JM; Ward KC; McCullough LE
    JAMA Netw Open; 2024 Jun; 7(6):e2416499. PubMed ID: 38865125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial disparity in survival from estrogen and progesterone receptor-positive breast cancer: implications for reducing breast cancer mortality disparities.
    Rauscher GH; Silva A; Pauls H; Frasor J; Bonini MG; Hoskins K
    Breast Cancer Res Treat; 2017 Jun; 163(2):321-330. PubMed ID: 28251385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial disparities in individual breast cancer outcomes by hormone-receptor subtype, area-level socio-economic status and healthcare resources.
    Akinyemiju T; Moore JX; Ojesina AI; Waterbor JW; Altekruse SF
    Breast Cancer Res Treat; 2016 Jun; 157(3):575-86. PubMed ID: 27255533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial differences in the incidence of breast cancer subtypes defined by combined histologic grade and hormone receptor status.
    Cunningham JE; Montero AJ; Garrett-Mayer E; Berkel HJ; Ely B
    Cancer Causes Control; 2010 Mar; 21(3):399-409. PubMed ID: 20024610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors That Contributed to Black-White Disparities in Survival Among Nonelderly Women With Breast Cancer Between 2004 and 2013.
    Jemal A; Robbins AS; Lin CC; Flanders WD; DeSantis CE; Ward EM; Freedman RA
    J Clin Oncol; 2018 Jan; 36(1):14-24. PubMed ID: 29035645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparities in Socioeconomic Factors Mediate the Impact of Racial Segregation Among Patients With Hepatopancreaticobiliary Cancer.
    Munir MM; Woldesenbet S; Endo Y; Moazzam Z; Lima HA; Azap L; Katayama E; Alaimo L; Shaikh C; Dillhoff M; Cloyd J; Ejaz A; Pawlik TM
    Ann Surg Oncol; 2023 Aug; 30(8):4826-4835. PubMed ID: 37095390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.